Google Chrome
Safari
Firefox
Edge
Continuous Manufacturing of Oral Solid Dosage Forms
Date:
2024/04/16
to 2024/04/18
Location:
Portugal
Search
News / Sep 23, 2021
Hovione awarded with the COTEC INNOVATIVE 2021 statute
Innovation potential in profitable growth and financial strength
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement
Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Press Release / Sep 26, 2025
Hovione honored with the Leonardo da Vinci Prize 2025
Presented by the Hénokiens Association and the Château du Clos Lucé
News / Sep 17, 2021
World Patient Safety Day 2021
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.